CLPP and pneumonia: Therapeutic efficacy was evaluated in a murine pneumonia model.<h4>Results</h4>Polydatin showed limited antibacterial activity but significantly inhibited ClpP and reduced the expression of key virulence factors, including Hla, PVL, and RNAIII.